FDA 483 - ITM Medical Isotopes GmbH - March 20, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of ITM Medical Isotopes GmbH in Garching B. Munchen, Germany, a manufacturer of pet drugs and sterile radioactive APIs, revealed significant deficiencies in their quality system. The firm failed to conduct adequate investigations into product failures and market complaints, particularly concerning product breakthrough prior to expiration. Additionally, the inspection found incomplete or inadequate written quality assurance procedures for recalls, OOS results, method validation, processing, calibration, and shipping validation.
ID · a85fbeef-c108-475f-8cc0-e79c79c0aa49